[September 2022]
Paris, France – Plantibodies is pleased to announce the successful closing of a €280,000 seed funding round, backed by Angels Santé, Europe’s first network of business angels specialized in healthcare, and the Badge network, one of France’s most active groups of business angels.
This fundraising milestone will accelerate the development of Plantibodies’ proprietary platform for plant produced biologics. The funds will support further proof-of-concept work, early preclinical studies, and the strengthening of IP and industrial partnerships.
“This financing is a key step forward for Plantibodies,” said Pierre Bauër, CEO and co-founder of Plantibodies. “It not only validates our vision but also brings on board investors with deep expertise in healthcare and industrialization. Their trust and support will be instrumental as we continue to push the boundaries of biologics bioproduction.”
For Angels Santé and Badge, this investment reflects their strategy of supporting high-potential healthtech startups that address critical unmet medical needs and contribute to the emergence of European deeptech champions.
Full announcement available here: Actu Business Angels press release